Health charities love to talk about purpose. They talk less about discipline. Listening to British Heart Foundation’s CMO, Claire Sadler, it’s clear purpose is not enough. Growth in the sector needs the mindset and methods of a product company: clear value exchange, proof of impact, and relentless clarity. I believe that’s the only way public trust turns into steady support.
Too many campaigns ask for attention without earning it. Too many teams chase reach instead of results. Charities should act like product teams: test, learn, ship, repeat. That is how a brand wins both hearts and wallets—and how research gets funded for the long haul.
What Growth Should Mean for Charities
Growth is not just more donations. It is stronger loyalty, better data, smarter spend, and a sharper story. British Heart Foundation sits at a rare junction: research funder, retail chain, and national educator. That mix can be a superpower if treated like a product suite with a single promise.
The goal should be simple: make it easy for someone to understand the cause, see their role, and act right now. If that path isn’t obvious, the marketing failed.
The Playbook We Need
Here is what a product-minded charity playbook looks like in practice.
- Make the “value” of a gift crystal clear: one pound equals a named action, with timelines and progress.
- Connect retail and research: link every store purchase to a live project update that donors can follow.
- Build first-party data with consent and care, then offer real benefits back—updates, early news, local events.
- Test channels like a lab: set a hypothesis, run small, report the lift, scale only what works.
- Tell human stories, not abstractions: a patient, a breakthrough, a next step—one story per ad.
- Budget like an investor: ringfence spend for experiments, with stage gates and clear kill criteria.
Each step turns a passive audience into active partners. It also respects people’s time and attention.
Why This Approach Works
Trust grows when people see movement. Show them the before and the after. Show what their action unlocked. Health causes can do this well: a new trial launched, a lab equipped, a guideline changed. That is the kind of proof that earns repeat giving.
Retail is an overlooked engine here. Every donated sofa, every impulse buy, and every tap at checkout is an entry point. Tie those micro-moments to live impact, and you turn stores into storytelling hubs. That is not glossy branding. That is practical marketing that pays for itself.
Data matters too—but only if handled with respect. Ask for what you need, explain why, and give something back. Even simple value—like tailored content, local alerts, or early invitations—can lift consent rates without tricks.
Answering the Doubts
Some will say this sounds cold. Charity is about heart, not funnels. I get that. But heart without method wastes goodwill. Method is how care becomes change.
Others argue that brand building should lead and performance should follow. That’s a false choice. Great brands are built by great experiences. When people see and feel progress, brand follows.
What Needs to Happen Next
Senior teams should stop treating campaigns as one-offs. Treat them as releases in a roadmap. Decide what “success” means ahead of time, and make that public. Hold the team to it. Celebrate the wins. Retire what failed. Then try again. That rhythm builds confidence inside and outside the organization.
Leadership also needs to align on one story. Heart research is vast. But audiences remember one idea at a time. Pick the idea for this quarter. Drive it across ads, shops, email, and PR. Measure how many people moved from awareness to action. Then pick the next idea.
I am tired of charity work that tries to do everything at once. Focus is not cold. Focus is kind. It respects donors, patients, and staff. It also respects the mission.
A Call For Accountable Growth
My take is simple: treat the mission like a product and the public like partners. Earn attention. Prove progress. Invite action. Repeat. That is how a modern charity grows with integrity.
If you care about this issue, ask charities for clear paths to action and proof of results. If you lead one, set a roadmap, publish your bets, and share what you learn. The cause deserves marketing that works as hard as the science.
Heart disease will not wait. Neither should our standards.
